Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor.
Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor. Oncotarget. 2016 Apr 05; 7(14):18171-82.
View in:
PubMed
subject areas
A549 Cells
Animals
Antineoplastic Agents
Biomarkers, Tumor
Cell Line, Tumor
Cell Proliferation
COS Cells
GTPase-Activating Proteins
Humans
Mice
Mice, Inbred NOD
Mice, SCID
Naphthyridines
Neoplasm Proteins
Neoplasms
Phosphorylation
Protein Kinase Inhibitors
Signal Transduction
Xenograft Model Antitumor Assays
authors with profiles
Yusuke Nakamura